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The Lyt-2/Lyt-3 (Lyt-2/3) glycoprotein complex is only expressed on the surfaces 
of particular subpopulations of thymus-derived (T) lymphocytes in the mouse. Among 
the cells that express Lyt-2/3 are the vast majority ofcytotoxic and suppressor T cells, 
but relatively few of the helpers (1, 2). Recently, functional studies with monoclonal 
antibodies against Lyt-2 have suggested that the Lyt-2/3 complex is associated with 
the antigen-binding structures on T cells (3-5). Therefore, we have asked whether the 
Lyt-2 polypeptides made in nonclonal cell populations are heterogeneous, as expected 
for diverse antigen receptors, or uniform. We report here that the Lyt-2 glycoproteins 
are subject to rapid post-translational processing, but that the newly synthesized 
molecules are unique. 
Mater ia ls  and  Methods  
Animals and Cells. Inbred C57BL/6(B6), C57BL/6-Lyt-2.1 (B6-Lyt-2.1), and C57BL/6-Lyt- 
2.1 Lyt-3.1 (B6-Lyt2.1/3.1) mice (6) were bred in our colony at the Salk Institute. Thymocyte 
suspensions were prepared as described previously (7-9) from animals 3-6 wk old. 
Metabolic Labeling and Immune Precipitation. Thymocytes were incubated with [aSS]methionine 
at 37°C as described previously (7, 8). In most experiments, Lyt-2/3 complexes were immuno- 
precipitated from detergent lysates of the labeled cells using the monoclonal antibody 19/178 
(3). Alternatively, the rat monoclonal antibody 53.6.72 (10) was used with a goat anti-rat Ig 
second-stage r agent. Conditions for preparation of lysates and immune precipitates, electro- 
phoresis in sodium dodecyl sulfate (SDS) -containing els, and fluorography were as.described 
previously (7-9, 11). In all cases, samples were analyzed under reducing conditions. 
Endoglycosidase H Digestion. After immunoprecipitation, samples were eluted from the Staphy- 
lococcus aureus immunoadsorbent (Pansorbin; Calbiochem-Behring Corp., American Hoechst 
Corp., San Diego, CA) and incubated with endo-fl-N-acetylglucosaminidase H ( ndo H) 
overnight (7, 8), using 3-10 p,g/ml of endo H for complete digestion. Dr. P. W. Robbins 
(Massachusetts Institute of Technology) donated the endo H. 
Two-dimensional Nonequilibrium pH Gradient Electrophoresis (NEPHGE) and SDS Gel Electrophore- 
sis. First-dimension NEPHGE electrophoresis (12) was for 1,800 V-h in 4% polyacrylamide 
tube gels with 1.6% pH 5-7 ampholines and 0.4% pH 3.5-10 ampholines (LKB Instruments, 
Inc., Rockville, MD). Second-dimension SDS gel electrophoresis was c rried out in 10.5% 
polyacrylamide g ls. 
Results and  Discussion 
Sizes of Newly Synthesized Lyt-2/3 Glycoproteins. Antibodies against either Lyt-2 or 
Lyt-3 precipitate similar disulfide-linked complexes of glycoproteins (13-17). These 
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can be dissociated into three types of components with apparent molecular weights of 
~30,000, 30,000-34,000, and 35,000-38,000 (15-17). This heterogeneity may result 
from differences in carbohydrate structure, and so we have attempted to define the 
forms that the Lyt-2/3 glycoproteins display before extensive carbohydrate processing 
has taken place. 
To label newly synthesized proteins selectively, thymocytes were incubated with 
[3~S]methionine for 10 rain. The Lyt-2/3 molecules labeled in these cells migrated in 
SDS-polyacrylamide gels as two sharply-defined species with apparent molecular 
weights of 31,000 (31 K) and 35,000 (35 K). To study the peptide moieties of these 
molecules, we digested pulse-labeled Lyt-2/3 immunoprecipitates with the glycosidase 
endo H. This enzyme selectively removes newly added carbohydrate from asparagine 
linkage sites, leaving only one sugar residue attached to the polypeptide (18, 19). 
Complete endo H digestion resulted in the replacement of the 31 K and 35 K 
components by molecules with apparent molecular weights of 20,000 (20 K) and 
24,000-25,000 (24 K) (Fig. 1 a, lane 3), which represent the maximum sizes for their 
polypeptide backbones. The specificity of the enzyme treatment was confirmed by its 
failure to alter the mobility of immunoglobulin ~ chains (cf. lanes 4 and 5), which are 
not glycosylated (20). 
High-Mannose Carbohydrate Chains in the Lyt-2/3 Complex. To determine the number 
of carbohydrate chains associated with Lyt-2/3, we carried out partial digestions with 
limiting concentrations of endo H. The sizes of the resulting products are summarized 
in Table I. In this experiment, he Lyt-2/3 species howed slightly higher apparent 
sizes, relative to the markers, than they did in most cases, and the native 31 K and 35 
K species migrated as molecules of 32,000 and 36,000 dahons. With limited exposure 
to the enzyme, discrete digestion intermediates were generated with apparent masses 
of 28,000-29,000 daltons and 24,000 dahons. These disappeared when digestion was 
complete, leaving major end products of ~24 and 20 kilodahons (Kd). This pattern 
indicated that a total of six carbohydrate chains could be removed from the two major 
glycoproteins, with a shift of 3,500-4,000 in apparent molecular weight as each one 
was cleaved. 
Because the two major glycoproteins also differ in size by 4 Kd, it was difficult to 
separate their respective digestion intermediates. In several experiments, however, the 
relative labeling intensities uggested that the 24 K endo H product originated from 
the 35 K component, while the 20 K product was derived from the 31 K component 
(data not shown). This suggests that each component carried three carbohydrate 
chains. 
Rapid Post-Translational Processing. To compare the newly made glycoproteins with 
components of cell-surface Lyt-2/3 complexes, we traced the fate of the pulse-labeled 
molecules during a nonradioactive chase. After a 10-min labeling period, thymocytes 
were cultured in excess cold methionine for intervals from 20 min to 4 h before they 
were lysed. As shown in Fig. 1 b, the molecules recognized by anti-Lyt-2 changed 
rapidly in the course of the chase. 
Within the first 20 min, a new, heavily labeled component appeared in the size 
range of 38-40 Kd. This migrated as a heterogeneous mixture of species (Fig. 1 b, 
lane 2) and probably represents the 38 Kd cell-surface form of Lyt-2 reported by 
others (14-17). Once generated, this component was quantitatively stable throughout 
4 h of chase (Fig. 1 b, lanes 2-5). In contrast, the pulse-labeled Lyt-2/3 species were 
all unstable. The intensity of the 35 K band dropped abruptly in the first 20 min and 
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Fxc. 1. Structural analysis and post-translational processing of biosynthetically labeled Lyt-2/3 
complexes. (a) Newly synthesized Lyt-2/3 glycoproteins before and after glycosidase treatment. Lyt- 
2/3 complexes synthesized by pulse-labeled B6 thymocytes (lanes 2, 3). Immunoglobulin molecules 
made by pulse-labeled splenocytes were precipitated with a rabbit anti-mouse Ig serum (lanes 4, 5). 
The samples were mock digested (lanes 2, 4) or digested to completion with endo H (lanes 3, 5). 
Lane 1 is a normal mouse serum precipitate from the thymocyte lysate. Inputs of radioactive protein 
before precipitation were l0 s cpm for lanes 1-3 and 5 × 105 cpm for lanes 4 and 5. Samples were 
fractionated in a 12.5% polyacrylamide gel. (b) Kinetics of processing of Lyt-2/3 complexes. 
Thymocytes pulse abeled as in panel (a) were incubated in nonradioactive medium (chase) for the 
lengths of time indicated, before lysis. Lyt-2/3 complexes were then precipitated from samples 
containing 9 × l0 s cell equivalents of lysate. The inputs of radioactive protein decreased from 1.3 
× 10 s cpm in the pulse-labeled sample to 7.4 × 105 cpm at 240 rain of chase. Samples were analysed 
by electrophoresis in a 10.5% polyacrylamide g l. 
more slowly thereafter.  The  31 K species lost rad ioact iv i ty  th roughout  the chase, 
perhaps g iv ing rise to a series of  discrete degradat ion  products  that  appeared  in the 
range of 28-30 kd. 
The  dramat ic  appearance  of  the 38 kd form could indicate that a new glycoprotein,  
itself unable  to react with ant i -Lyt-2 ant ibodies,  became prec ip i tab le  when it was 
added to the complex  20 rain after it was made.  However ,  the amount  of  rad ioact iv i ty  
specif ically prec ip i tated id not increase dur ing  the first 20 min  of  chase, as determined  
by densi tometr ic  scanning of  the 31-38-kd regions of  the or ig inal  autorad iogram 
(data not shown). Therefore,  it seems more l ikely that  all components  of  the complex  
were assembled with in  the first I0 min  o f  synthesis, and that  the 38-kd molecules 
were generated from the 35 K or 31 K fo rms  by further e laborat ion o f  their  
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carbohydrate  s t ructures .  Th is  p rocess ing  is notab ly  more  rap id  than  that  observed  for 
the  o ther  thymocyte  g lycoprote ins  TL  (7) and  Q,a-1 (8). 
The  xenogene ic  monoc lona l  ant ibody ,  53.6.72 (10), wh ich  recogn izes  a d i f fe rent  
s t ruc ture  on  the  Lyt -2  ant igen ,  p rec ip i ta ted  molecu lar  spec ies  that  were  ident ica l  in
size and  re la t ive  in tens i ty  to those  observed  us ing  the  a l le le -spec i f i c  monoc lona l  
TABLE I 
Products of Partial Endo H Digestion of the Lyt-2/3 Complex* 
Endo H dose Otg/ml) 
0.0 0.1 0.3 1.0 10.0 




X lO  ,~ 
(32) (32) 
29 
25 25 25 
24 
20 20 20 
* Lyt-2/3 complexes were immune-precipitated from a lysate f pulse-l beled B6 thymocytes. 
:~ Faint bands are denoted by parentheses. 
§ Apparent molecular weights were calibrated by the migration of ~4C-methyl labeled standards (New 
England Nuclear, Boston, MA) on the same 12.5% polyacrylamide g l: bovine serum albumin (69,000 
tool wt), ovalbumin (46,000 tool wt), carbonic anhydrase (30,000 tool wt), and lactoglobulin A (18,300 
tool wt). 
FIe;. 2. Two-dimensional nalysis of pulse-labeled Lyt-2. Lyt-2/3 complexes were precipitated 
from detergent lysates of thymocytes from B6-Lyt2.1/3. l (A), B6-Lyt2.1 (B), and B6 (C) mice. In D 
and E, equal amounts of the lysates used in A and C were mixed before precipitation with anti-Lyt- 
2 (D) or normal mouse serum (E). Precipitates were eluted from the S. aureus immunoadsorbent and 
analyzed as described in Materials and Methods. The fluorographs are oriented so that the top of 
the NEPHGE gel (acidic end) is on the left. 2.1, presumptive Lyt-2.1 gene product. 2.2, presumptive 
Lyt-2.2 gene product. Both co-migrate with the 35 K band shown in Fig. 1. 
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antibody, 19/178 (data not shown). This makes it unlikely that conformational 
changes during processing either obscure or create the determinant recognized by the 
19/178 antibody. 
A Single Molecular Species Controlled by the Lyt-2 Locus. To study the product of 
Lyt-2 gene selectively, we made use of the B6 mouse strains congenic at the Lyt-2 locus 
(6). The molecule specified by Lyt-2 was identified by comparison of the pulse-labeled 
products of B6 (Lyt 2.2; Lyt 3.2), B6-Lyt 2.1 (Lyt 3.2), and B6-Lyt 2.1:3.1 thymocytes, 
using the xenogeneic monoclonal antibody, 53.6.72, to precipitate Lyt-2/3 complexes. 
The samples were fractionated in the first dimension by NEPHGE and then by 
electrophoresis in SDS-polyacrylamide g ls (12) (Fig. 2). In each case, the 35 K Lyt- 
2/3 component appeared as a single prominent spot. It was symmetrical in form and 
showed no evidence of heterogeneity. There was no size difference between the 35 K 
molecules made by thymocytes of Lyt 2.1 and Lyt 2.2 genotypes, but a charge 
difference was apparent. The 35 K spot from thymocytes of B6-Lyt 2.1:3.1 or B6-Lyt 
2.1:3.2 mice (Fig. 2, panels A, B) was distinctly more basic than the 35 K spot from 
B6 (Lyt 2.2/3.2) thymocytes (Fig. 2, panel C). The separation was clear when the 
samples from panels A and C were mixed before immune precipitation and gel 
analysis (Fig. 2, panel D). Thus, the isoelectric point of the 35 K Lyt-2/3 component 
was determined by the allele at the Lyt-2 locus. 
We conclude that each Lyt-2 allele encodes a polypeptide that is homogeneous but 
subject to rapid post-translational processing. Both the 35- and 38-Kd cell-surface 
molecules appear to be glycosylated erivatives of this initial product. Although 
separate T cell clones may express the 38- and 35-Kd forms of Lyt-2 in different ratios 
(17), this probably reflects differences in the extent of carbohydrate processing rather 
than the activation of different Lyt-2 structural genes. 
Summary  
We investigated the possibility that the Lyt-2 molecules made by uncloned mouse 
T lymphocytes would show variable primary structtlres like those of immunoglobulins. 
Newly synthesized Lyt-2/3 complexes were found to include only two major compo- 
nents, both discrete glycoproteins with apparent molecular weights of 31,000 (31 K) 
and 35,000 (35 K). When products of Lyt-2.1 and Lyt-2.2 thymocytes were compared 
by two-dimensional nonequilibrium pH gradient electrophoresis and sodium dodecyl 
sulfate polyacrylamide g l electrophoresis, the isoelectric points of the 35 K molecules 
were different; thus, the 35 K component was likely to be encoded by the Lyt-2 locus 
itself. However, the 35 K molecules made by any one genotype were homogeneous in 
charge as well as in size. The homogeneity was obscured rapidly by post-translational 
modification. Most strikingly, within 30 min of initial synthesis, these processing 
events generated the conspicuous array of microheterogeneous products that form the 
"38 K" component of cell-surface Lyt-2/3. 
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